Related Experiment Video
Updated: Nov 25, 2025
09:21
Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
7.4K
Establishment and Characterization of a Sclerosing Spindle Cell Rhabdomyosarcoma Cell Line with a Complex Genomic
Sabine Schleicher1, Stefan Grote1, Elke Malenke1
1Department of Hematology and Oncology, Eberhard Karls University Tuebingen, Children's Hospital, 72076 Tuebingen, Germany.
Cells
|December 16, 2020
Summary
A new cell line, SRH, derived from adult sclerosing spindle cell rhabdomyosarcoma (SSRMS), offers a valuable model for studying this rare cancer and developing new treatments.
Area of Science:
- Oncology
- Cancer Biology
- Genetics
Background:
- Sclerosing spindle cell rhabdomyosarcoma (SSRMS) is a rare subtype of rhabdomyosarcoma (RMS).
- Cases with MYOD1 mutations show high recurrence and metastasis rates.
- SSRMS cell lines are crucial for understanding disease mechanisms and preclinical drug evaluation.
Purpose of the Study:
- To characterize a newly established cell line from an adult SSRMS tumor.
- To evaluate its potential as a preclinical research model.
Main Methods:
- Immunohistochemistry, growth characteristics, cytogenetic analysis, mutation analysis.
- Stem cell marker expression, differentiation potential, and in vivo tumorigenicity in mice.
- Array-comparative genomic hybridization (CGH) was performed.
Main Results:
- The SRH cell line exhibited a complex genomic profile with gene locus loss.
- Mesenchymal markers were expressed, with potential for adipogenic and osteogenic differentiation.
- Despite MYOD1 mutation, terminal myogenic differentiation was inhibited; in vivo tumorigenicity was confirmed.
Conclusions:
- The SRH cell line is the first characterized adult SSRMS cell line.
- It serves as a valuable in vitro and in vivo model for preclinical research on this rare RMS subtype.
- This model can aid in developing novel therapeutic strategies for SSRMS.
